AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44

Authors: BISCHOFF ME BLAU W WAGNER T WAGENMANN W DORNER O BASARA N FAUSER AA
Citation: Me. Bischoff et al., TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IS A CONDITIONING REGIMENFOR UNRELATED BONE-MARROW TRANSPLANTATION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND RENAL-FAILURE ON HEMODIALYSIS, Bone marrow transplantation, 22(6), 1998, pp. 591-593

Authors: HERRMANN D SCHMETZER B SCHILZ A BLAU W ROEMER E BISCHOFF M KIRSTEN D RUDOLPHI M GUNZELMANN S SANCHEZ H FAUSER AA
Citation: D. Herrmann et al., COLLECTION OF CORD BLOOD STEM-CELLS FOR TRANSPLANTATION, Bone marrow transplantation, 22, 1998, pp. 37-37

Authors: BASARA N BLAU WI ROMER E RUDOLPHI M BISCHOFF M KIRSTEN D SANCHEZ H GUNZELMANN S FAUSER AA
Citation: N. Basara et al., MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS, Bone marrow transplantation, 22(1), 1998, pp. 61-65

Authors: BASARA N BISCHOFF M BLAU IW HERMANN D ROMER E RUDOLPHI M KIRSTEN D SANCHEZ H FAUSER AA
Citation: N. Basara et al., A 2ND UNRELATED BONE-MARROW TRANSPLANT WITH AN UNRELATED DONOR MARROW- TREATMENT OF A PATIENT WITH RELAPSED LEUKEMIA, Bone marrow transplantation, 21(3), 1998, pp. 291-293

Authors: BLAU IW HERRMANN D SCHMETZER B ROEMER E BISCHOFF M FAUSER AA
Citation: Iw. Blau et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE - EXPERIENCE WITH 52 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS, Bone marrow transplantation, 21, 1998, pp. 10-10

Authors: GENGENBACHER D GUNZELMANN S RUDOLPHI M BLAU W BENDER M SCHMETZER B HERRMANN D KIRSTEN D SANCHEZ H ROEMER E BISCHOFF M FAUSER AA
Citation: D. Gengenbacher et al., GRAFT VERSUS LYMPHOMA REACTION IN STAGE-IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION AND REPEATED STEM-CELL REINFUSION, Bone marrow transplantation, 21, 1998, pp. 36-36

Authors: ARNOLD R BUNJES D DEEG HJ EINSELE H FAUSER AA FINKE J HERTENSTEIN B HEYLL A KOLB HJ KOLBE K MARTIN H NIEDERWIESER D SCHAEFER UW SCHMITZ N SCHWERDTFEGER R SIEGERT W WANDT H ZANDER A GOEKBUGET N HOELZER D
Citation: R. Arnold et al., BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES, Bone marrow transplantation, 21, 1998, pp. 2-2

Authors: KIRSTEN D BLAU IW BASARA N RUDOLPHI M BISCHOFF M ROEMER E FAUSER AA
Citation: D. Kirsten et al., ALLOGENEIC BMT PBSCT IN PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIAAND LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE/, Bone marrow transplantation, 21, 1998, pp. 136-136

Authors: ROEMER E BLAU IW BISCHOFF M GUNZELMANN S RUDOLPHI M KIRSTEN D FAUSER AA KIEHL MG
Citation: E. Roemer et al., MULTIORGAN FAILURE (MOF) AS THE MOST FREQUENT CAUSE OF EARLY TRANSPLANT-RELATED MORTALITY (TRM), Bone marrow transplantation, 21, 1998, pp. 320-320

Authors: BASARA N BLAU W KIEHL MG ROMER E RUDOLPHI M BISCHOFF M KIRSTEN D SANCHEZ H GUNZELMANN S FAUSER AA
Citation: N. Basara et al., THE EFFICACY AND SAFETY OF MYCOPHENOLATE MOFETIL (MMF) IN THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS, Bone marrow transplantation, 21, 1998, pp. 407-407

Authors: RUDOLPHI M BLAU IW ROMER E BISCHOFF M FAUSER AA KIEHL MG
Citation: M. Rudolphi et al., DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) AND TRANSBRONCHIAL BIOPSY (TBB) IN PATIENTS AFTER ALLOGENEIC BRIT, Bone marrow transplantation, 21, 1998, pp. 507-507

Authors: ROEMER E BLAU IW BISCHOFF M GUNZELMANN S SANCHEZ H RUDOLPHI M KIRSTEN B GENGENBACHER D FAUSER AA
Citation: E. Roemer et al., SUCCESSFUL TREATMENT OF CEREBRAL TOXOPLASMOSIS FOLLOWING ALLOGENEIC BMT PBSCT/, Bone marrow transplantation, 21, 1998, pp. 518-518

Authors: RUDOLPHI M BASARA N FAUSER AA BLAU IW
Citation: M. Rudolphi et al., SEVERE COMPLICATION AFTER ALLOGENEIC BMT - PNEUMOTHORAX AND MEDIASTINAL EMPHYSEMA IN A PATIENT WITH BOOP (BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA), Bone marrow transplantation, 21, 1998, pp. 557-557

Authors: RUDOLPHI M ROMER E BISCHOFF M KIRSTEN D GUNZELMANN S KIEHL MG BLAU IW FAUSER AA
Citation: M. Rudolphi et al., BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT), Bone marrow transplantation, 21, 1998, pp. 558-558

Authors: GENGENBACHER D GUENZELMANN S SCHMETZER B ROMANAKIS K BENDER M BISCHOFF M FAUSER AA
Citation: D. Gengenbacher et al., MONITORING OF GRAFT FUNCTION AND RESIDUAL LEUKEMIA BY CELL-CYCLE KINETICS AND DRUG-RESISTANCE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 633-633

Authors: RICHTER E EICHLER H RASKE D HERRMANN D BLAU W KEROWGAN M FAUSER AA GOLDMANN SF
Citation: E. Richter et al., PERIPHERAL-BLOOD STEM-CELL MOBILIZATION BY G-CSF IN RELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 670-670

Authors: SCHILZ AJ BROUNS G KNOSS H OTTMANN O HOELZER D FAUSER AA THRASHER A GREZ M
Citation: Aj. Schilz et al., EFFICIENT GENE-TRANSFER TO HUMAN REPOPULATING CELLS, Molecular immunology, 35(11-12), 1998, pp. 722-722

Authors: GENGENBACHER DM ROMANAKIS K KNIPPER R SCHMETZER B BENDER M FAUSER AA
Citation: Dm. Gengenbacher et al., IMPACT OF CELL-CYCLE ANALYSIS AND DRUG-RESISTANCE FOR MONITORING AND FOLLOW-UP OF HEMATOLOGIC MALIGNANCIES, British Journal of Haematology, 102(1), 1998, pp. 331-331

Authors: SCHILZ AJ BROUNS G KNOSS H OTTMANN OG HOELZER D FAUSER AA THRASHER AJ GREZ M
Citation: Aj. Schilz et al., HIGH-EFFICIENCY GENE-TRANSFER TO HUMAN HEMATOPOIETIC SCID-REPOPULATING CELLS UNDER SERUM-FREE CONDITIONS, Blood, 92(9), 1998, pp. 3163-3171

Authors: FAUSER AA RUSS W BISCHOFF M
Citation: Aa. Fauser et al., ORAL DOLASETRON MESILATE (MDL-73,147EF) FOR THE CONTROL OF EMESIS DURING FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE CYCLOPHOSPHAMIDEIN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Supportive care in cancer, 5(3), 1997, pp. 219-222

Authors: BASARA N BLAU W ROMER E RUDOLPHI M BISHOFF M KIRSTEN D SANCHEZ H GUNZELMANN S FAUSER AA
Citation: N. Basara et al., MYCOPHENOLATE MOFETIL (MMF) FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS, Experimental hematology, 25(8), 1997, pp. 548-548

Authors: GENGENBACHER DM BLAU IW ROEMER E RUDOLPHI M BISCHOFF M KIRSTEN D SANCHEZ H GUENZELMANN S THIELE B FAUSER AA
Citation: Dm. Gengenbacher et al., IMPACT OF HLA-MISMATCH FOR GRAFT-VERSUS-HOST DISEASE AND CHIMERISM INUNRELATED BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME, Human immunology, 55, 1997, pp. 129-129

Authors: GENGENBACHER DM ROMANAKIS R SCHMETZER B GUENZELMANN S BENDER M HERRMANN D BLAU IW BISCHOFF M SANCHEZ H ROEMER E THIELE B RUDOLPHI M KIRSTEN D FAUSER AA
Citation: Dm. Gengenbacher et al., CLINICAL-SIGNIFICANCE OF DRUG-RESISTANCE AND CELL-CYCLE ANALYSIS IN ACUTE-LEUKEMIA DURING CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 3639-3639

Authors: BLAU IW HERRMANN D SCHMETZER B GENGENBACHER DM BISCHOFF M BASARA N FAUSER AA
Citation: Iw. Blau et al., ANALYSIS OF THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION OF 55 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS, Blood, 90(10), 1997, pp. 4396-4396

Authors: RUDOLPHI M BASARA N BISCHOFF M BLAU IW GENGENBACHER DM GUNZELMANN S SCHMETZER B HERRMANN D ROMER E KIRSTEN D SANCHEZ H FAUSER AA
Citation: M. Rudolphi et al., INDUCTION OF GRAFT VERSUS LYMPHOMA REACTION IN STAGE IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT- COMPARISON OF LABORATORY, RADIOLOGICAL AND CLINICAL FINDINGS, Blood, 90(10), 1997, pp. 4475-4475
Risultati: 1-25 | 26-44